Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

GLOBAL: GAVI to Cover 30M Girls with HPV Vaccines




 

Africa Science News (12.06.12)

The GAVI Alliance will work with multiple developing countries to ensure that they have the infrastructure and capacity to fully vaccinate young women for the human papillomavirus (HPV), which causes most cervical cancers. About 275,000 women die from cervical cancer annually, and more than 85 percent of these deaths occur in developing nations. The demand for HPV vaccination has exceeded the supply in these locations, where routine preventive care—immunizations, screening, and treatment—is not available to many women. GAVI will work with nations to identify the target groups who will receive HPV vaccination and to ensure that the infrastructure for fully administering the vaccinations is in place. Use of schools as a vaccination setting has been successful in pilot projects. Pilots will begin—primarily in sub-Saharan African countries—in 2013. GAVI’s goal is to immunize 1 million girls by 2012 and more than 30 million girls by 2020. GAVI has negotiated with manufacturers to supply the vaccine for $5 per dose in 2012, which is a 64 percent reduction in the market price. Rwanda and Uganda have already piloted vaccination efforts and will roll out programs in 2013. Vaccinating girls before they become sexually active is a critical strategy to prevent cervical cancer. Estimates suggest that the HPV vaccination can prevent about 70 percent of cervical cancers.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in December 7, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.